Constituent country inequalities in myocardial infarction incidence and case fatality in men and women in the United Kingdom, 1996-2005

Journal of Public Health

Volumn 33, Issue 1, 2011, Pages 131-138

  Davies, A R ^a,b   Grundy, E ^a   Nitsch, D ^a   Smeeth, L ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

case fatality; incidence; myocardial infarction; trends; United Kingdom

Indexed keywords

EID: 79952182051     PISSN: 17413842     EISSN: 17413850     Source Type: Journal    
DOI: 10.1093/pubmed/fdq049     Document Type: Article

References (39)

1. Allender S, Peto V, Scarborough P et al. Coronary Heart Disease Statistics. London: British Heart Foundation, 2007.
2. Charlton J, Murphy M, Khaw KT et al. Cardiovascular disease. In: Charlton J, Murphy MB (eds). The Health of Adult Britain, 1841- 1994. London: The Stationary Office, 1997, 60-81.
3. Scarborough P, Allender S, Peto V et al. Regional and social differences in Coronary Heart Disease. London: British Heart Foundation, 2008.
4. Tunstall-Pedoe H, Kuulasamaa K, Mähönen M et al. Contribution of trends in survival and coronary-events rates to changes in coronary heart disease mortality: 10 years results from 37 WHO MONICA Project populations. Lancet 1999;353:1547-57. (Pubitemid 29219203)
5. Lampe FC, Morris RW, Walker M et al. Trends in rates of different forms of diagnosed coronary heart disease, 1978 to 2000: prospective, population based study of British men. BMJ 2005; 330(7499):1046-9. (Pubitemid 40646552)
6. Capewell S, Livingston BM, MacIntyre K et al. Trends in casefatality in 117718 patients admitted with acute myocardial infarction in Scotland. Eur Heart J 2000;21(22):1833-40.
7. Office of Public Sector Information. Government of Wales Act 1998 (c. 38), 1998.
8. Office of Public Sector Information. Scotland Act, 1998.
9. Office of Public Sector Information. Northern Ireland (Elections) Act, 1998.
10. Office of Public Sector Information. The Northern Ireland Act 2000 (Restoration of Devolved Government) Order, 2007.
11. Department of Health. Coronary Heart Disease: National Service Framework for Coronary Heart Disease-Modern Standards and Service Models. London: Department of Health, 2000.
12. The National Assembly for Wales. Tackling CHD in Wales: Implementing Through Evidence. Cardiff: National Assembly for Wales, 2001.
13. The Scottish Office. Coronary Heart Disease and Stroke: Strategy for Scotland. In: Office TS (eds). Edinburgh: The Scottish Office, 2002.
14. Norris RM on behalf of the United Kingdom Heart Attack Study Collaborative Group. Fatality outside hospital from acute coronary events in three British health districts, 1994-5. BMJ 1998;316(7137):1065-70.
15. Moore W, Kee F, Evans A et al. Pre-hospital coronary care and coronary fatality in the Belfast and Glasgow MONICA populations. Int J Epidemiol 2005;34(2):422-30. (Pubitemid 40645333)
16. Lewis JD, Schinnar R, Bilker WB et al. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 2006;16(4):393-401. (Pubitemid 46656860)
17. Bourke A, Dattani H, Robinson M. Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care 2004;12:171-7. (Pubitemid 39534583)
18. Office for National Statistics. Population Estimates for UK, England and Wales. Scotland and Northern Ireland, 2006.
19. Department of Health. New GMS Contract QOF Implementation: Dataset and Business Rules-Coronary Heart Disease Indicator Set, Version 5. London: Department of Health, 2004,32.
20. Lewis JD, Bilker WB, Weinstein RB et al. The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf 2005;14:443-51. (Pubitemid 40990739)
21. Maguire A, Blak BT, Thompson M. The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol Drug Saf 2009;18:76-83.
22. British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 2005.
23. Townsend P, Phillimore P, Beattie A. Health and Deprivation: Inequality and the North. London: Croom Helm, 1988.
24. Office for National Statistics. T01. Mid-2004 Population Estimates: United Kingdom; Estimated Resident Population by Single Year of Age and Sex; revised due to Harrow Correction. Office for National Statistics, 2005.
25. Kirkwood BR, Sterne JA. Standardisation. In: Kirkwood BR, Sterne JA (eds). Essential Medical Statistics, 2nd edn. Oxford: Blackwell Publishing Ltd, 2003,263-71.
26. Leyland A, Goldstein H. Multilevel Modelling of Health Statistics, 1st edn. Chichester: John Wiley & Sons, 2001.
27. Office for National Statistics. Regional Trends. In: Phillpotts G, Causer P (eds). London: Office for National Statistics, 2006.
28. European Observatory on Health Care Systems. Health Care Systems in Transition. United Kingdom: European Observatory on Health Care Systems, 1999.
29. Information Services Division NHS Scotland. http://www. isdscotland.org/isd/5779.html (9 April 2010, date last accessed).
30. Jick H, Derby LE, Gurewich V et al. The risk of myocardial infarction associated with antihypertensive drug treatment in persons with uncomplicated essential hypertension. Pharmacotherapy 1996;16:321-6. (Pubitemid 26161336)
31. Jick H, Jick S, Derby L. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991;302(6779):766-8.
32. Hammad TA, McAdams MA, Feight A et al. Determining the predictive value of Read/OXMIS codes to identify incident acute myocardial infarction in the General Practice Research Database. Pharmacoepidemiol Drug Saf 2008;12:1197-201.
33. Hubbard R, Lewis S, Smith C et al. Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death. Tob Control 2005;14(6):416-21. (Pubitemid 41759617)
34. Donaldson GC, Hurst JR, Smith CJ et al. Increased risk of myocardial infarction and stroke following exacerbation of chronic obstructive pulmonary disease. Chest 2009, doi: 10.1378/chest.09-2029.
35. Garcia Rodriguez LA, Varas C, Patrono C. Differential effects of aspirin and non-aspirin nonsteroidal antiinflammatory drugs in the primary prevention of myocardial infarction in postmenopausal women. Epidemiology 2000;11(4):382-7. (Pubitemid 30428929)
36. Garcia Rodriguez LA, Varas-Lorenzo C, Maguire A et al. Nonsteroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population. Circulation 2004;109(24): 3000-6. (Pubitemid 38808323)
37. Garcia Rodriguez LA, Tacconelli S, Patrignani P. Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population. J Am Coll Cardiol 2008;52:1628-36.
38. Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 2000;21(18):1502-13.
39. Packham C, Gray D, Weston C et al. Changing the diagnostic criteria for myocardial infarction in patients with a suspected heart attack affects the measurement of 30 day mortality but not long term survival. Heart 2002;88(4):337-42.